[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100592093":3},{"organization":4,"armGroups":7,"interventions":16,"overallOfficials":30,"centralContacts":35,"locations":40,"responsibleParty":57,"collaborators":11,"id":60,"slug":11,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":11,"eligibilityCriteria":65,"healthyVolunteers":66,"sex":67,"minAge":68,"maxAge":69,"enrollmentInfo":70,"targetDuration":11,"studyType":73,"phases":74,"briefSummary":76,"conditions":77,"keywords":85,"overallStatus":42,"whyStopped":11,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":99},{"fullName":5,"class":6},"The First Affiliated Hospital of Guangzhou Medical University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Digitally enabled low-dose CT screening Group","EXPERIMENTAL",null,[13,14,15],"Device: Low-dose CT screening","Device: AI full-lung model interpretation system","Device: Digital Health Platform",[17,22,26],{"type":18,"name":19,"description":20,"armGroupLabels":21,"otherNames":11},"DEVICE","Low-dose CT screening","Low-dose CT screening is conducted at primary healthcare institutions, and patients with detected lung nodules are referred to hospitals for further examination",[9],{"type":18,"name":23,"description":24,"armGroupLabels":25,"otherNames":11},"AI full-lung model interpretation system","Using artificial intelligence technology to assist in the interpretation of CT images",[9],{"type":18,"name":27,"description":28,"armGroupLabels":29,"otherNames":11},"Digital Health Platform","Community health centers and streets in Guangzhou use a program called \"Fei Anxin\" to manage residents' information in a unified way",[9],[31],{"name":32,"affiliation":33,"role":34},"Jianxing He, MD","Department of Cardiothoracic Surgery, the First Affiliated Hospital of Guangzhou Medical College","PRINCIPAL_INVESTIGATOR",[36],{"name":32,"role":37,"phone":38,"phoneExt":11,"email":39},"CONTACT","86-20-83337792","drjianxing.he@gmail.com",[41],{"facility":33,"status":42,"city":43,"state":44,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"RECRUITING","Guangzhou","Guangdong","510120","China","CN",{"type":49,"coordinates":50},"Point",[51,52],113.25,23.11667,{"lat":52,"lon":51},[55],{"name":32,"role":37,"phone":56,"phoneExt":11,"email":39},"+86-20-83337792",{"type":34,"investigatorFullName":58,"investigatorTitle":59,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"Jianxing He","Director","100592093",false,"NCT06988943","Early Intervention Strategies for Lung Cancer","Construction and Evaluation of a Hospital-Community Health Collaboration Model Empowered by Digital Technology for Lung Cancer Screening","1.Community Health Service Centers (Cluster Level)\n\n1. Inclusion Criteria The community health service center must be located within one of the 11 districts of Guangzhou.\n\n   The center must manage a population of over 10,000 elderly individuals. The center should be equipped with at least one CT machine and have qualified medical personnel, such as radiologists, radiologic technicians, and nursing staff.\n2. Exclusion Criteria Community health centers currently participating in other public health projects or studies that may affect screening results.\n\nCommunity health service centers where researchers cannot collect data or conduct follow-up.\n\n2\\. Screening Subjects (Individual Level)\n\n1. Inclusion Criteria Aged 40-75 years. Residing in the community participating in the study for a long time. No known history of lung cancer and has not undergone lung cancer screening in the past three months.\n\n   Able to understand and willing to sign the informed consent form, and able to participate in long-term follow-up.\n2. Exclusion Criteria Individuals diagnosed with lung cancer. Individuals with severe other health issues that make them unsuitable for CT imaging.\n\nIndividuals unable to understand the study protocol or who cannot provide informed consent due to cognitive impairments.\n\nIndividuals participating in other clinical trials that may affect the results of this study.\n\nIndividuals unable to undergo follow-up.",true,"ALL","40 Years","74 Years",{"count":71,"type":72},16000,"ESTIMATED","INTERVENTIONAL",[75],"NA","Low-dose CT (LDCT）can detect and treat lung cancer earlier and more quickly, while expanded screening coverage helps reduce the incidence and mortality of respiratory diseases such as lung cancer. This study aims to conduct a single-arm cluster randomized trial of digitally enabled LDCT in Guangzhou to assess its intervention effectiveness and cost-effectiveness.",[78,79,80,81,82,83,84],"Respiratory Tract Neoplasms","Thoracic Neoplasms","Neoplasms by Site","Neoplasms","Lung Diseases","Respiratory Tract Diseases","Lung Neoplasms",[86,87,88,89],"Screning test","Lung cancer","LDCT","Low-dose CT","2025-05-26",{"date":92,"type":93},"2025-05-30","ACTUAL",{"date":95,"type":93},"2024-06-25",{"date":97,"type":72},"2025-06",{"name":5,"class":6},1]